Warhound, a newly formed US-based defence startup, plans to create genetically engineered military dogs by cloning and editing embryos for use in military and security operations, and has raised $200 million in a seed funding round while reaching a $1.2 billion valuation without producing a single genetically modified pup.
The venture is backed by major investors, including Sequoia Capital, ARK Invest and Lux Capital. It brings together Palmer Luckey, founder of defence tech firm Anduril, and Ben Lamm, co-founder and CEO of Colossal Biosciences, the company that made a controversial effort to resurrect the extinct dire wolf.
Warhound says it will combine genetic engineering with protective equipment and digital systems designed to support dogs and their human handlers. The initiative grew out of what the company describes as a logistical vulnerability in US national security: the United States currently relies heavily on European suppliers for the majority of its military working dogs.
These dogs are important frontline assets for tracking, locating missing persons and sniffing out explosives in high-threat environments, and American agencies face international competition to secure the same elite canine stock. Traditional breeding and training cycles take around three years, and only a small percentage of purchased dogs meet the strict standards required for active military service.
Genetically engineered military dogs: development and timeline
Warhound plans to start with two breeds already valued for military and police work: Belgian Malinois and German Shepherds. Researchers associated with the project intend to clone the cells of those dogs and edit the cloned embryos to produce new puppies, with the first litters expected in early 2027.
The company says it aims to improve the dogs’ health and longevity as well as operational traits such as speed, agility and scent detection. “Man’s best friend deserves man’s best tech,” Palmer Luckey said in a statement.
